A unique integrated strategy and corporate and investment banking solution for global and emerging life science and healthcare companies.
The DNB // Back Bay Partnership strengthens companies with financial and strategic guidance on growth opportunities across sector and development stage—from private and emerging public life science and healthcare companies seeking partnering, licensing opportunities, M&A opportunities and listing support and execution on U.S. and Nordic exchanges to consolidators seeking and executing on acquisitions and other growth strategies.
ABOUT THE PARTNERSHIP
Nasdaq welcomed the DNB//Back Bay Partnership with a tribute on the Nasdaq Tower, May 2023, New York City.
The DNB // Back Bay Partnership was formalized in 2023 to provide healthcare companies with strategic guidance, M&A and partnering support and execution and capabilities in global capital markets and investment and commercial banking.
DNB, headquartered in Oslo, Norway, and Back Bay Life Science Advisors, headquartered in Boston, Massachusetts, are recognized leaders in global life science development and banking. Together, DNB and Back Bay Life Science Advisors offer unique support to companies along the full continuum of life science and healthcare development.
Learn more about the Partnership, subscribe for market insights and connect with our advisors. LEARN MORE >>
STAY CONNECTED!
DNB//BACK BAY PARTNERSHIP NEWS & EVENTS
ABOUT DNB
DNB is Norway’s largest financial institution and leading corporate and investment bank, with international expertise in corporate banking and public capital markets across selected industry sectors, specializing in arranging financing for healthcare companies globally.
DNB has been established in North America since 1975, with a full-service branch in New York that serves corporate customers in the bank’s strategic business areas. A full range of wholesale investment banking services is provided by DNB Markets, Inc., a U.S. registered broker-dealer and wholly owned subsidiary of DNB Bank ASA in New York, established in 2003. Visit DNB Bank’s healthcare pages to learn more, here.
ABOUT BACK BAY LIFE SCIENCE ADVISORS
Back Bay Life Science Advisors (Back Bay) provides life science strategy and investment banking guidance and execution to global life science companies and their investors. Back Bay’s integrated strategy and banking teams advise companies on all aspects of life science, healthcare technology and drug development, including planning an initial concept, product commercialization, franchise growth, licensing, partnering, M&A, divestiture and more.
With a strong presence in Europe and the Nordic markets and a global reach, Back Bay has guided hundreds of healthcare companies through the complexities of commercial development and transactions. Every project and transaction is rooted in Back Bay’s deep expertise in life science, healthcare industry strategy and investment banking. Learn more: www.bblsa.com
Our combined expertise in healthcare and banking spans more than 110 years and 1,000 successful projects and transactions.
To Learn more about the Partnership and to request an overview of our capabilities, connect below.